Drug intelligence / Profile preview

Lactobalance

Development stage: Unknown
Lead developer: Unipharm
Modality: Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
Administration: Oral

Overview

Lactobalance is a multi-strain probiotic dietary supplement designed to restore and maintain a healthy intestinal microbiota. It typically contains a combination of *Lactobacillus* and *Bifidobacterium* species, along with *Streptococcus thermophilus*. The supplement is used to manage intestinal dysbiosis, support immune function, and has been investigated as an adjunct therapy in conditions like allergic bronchial asthma and small intestinal bacterial overgrowth (SIBO) to normalize short-chain fatty acid (SCFA) production and reduce inflammation. By introducing beneficial live bacteria, it helps restore microbial diversity and the habitat of the intestinal biotope.

Brand names: Lactobalance
Other names: Лактобаланс

Beyond the preview

Go deeper on Lactobalance.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactobalance.

Explore the full profile